Subscribe for the newsletter
Sign in
Articles
Expert Interviews
Roundtable
Press Releases
Videos
The Road To Series
Market Research
Thought Leaders
More
Discovery
Small Molecules
Biologics
Advanced Therapies
Manufacturing
Supply Chain
Clinical Trials
Technologies
Financing
Opioid Withdrawal
Sort By
Newest First
1 / 1
1 / 1
Opioid Disorder
Braeburn Submits Request for Final Approval of BRIXADI for the Treatment of Opioid Use Disorder
Braeburn
PR-M06-20-NI-014
Jun 11, 2020
FDA Approval
New Treatment for Management of Opioid Withdrawal Symptoms Approved by FDA
Emilie Branch
Pharma's Almanac
PAO-M05-18-NI-019
May 24, 2018
FDA Approval
FDA approves the first non-opioid treatment for management of opioid withdrawal symptoms in adults
U.S. Food & Drug Administration
PR-M05-18-NI-079
May 21, 2018
